Skip to content
  • Mediacenter
  • Literature Database
  • Investor News
  • Careers
  • Get in Contact
International (English)
Locale
CytoSorbents Europe GmbH
International (English)
Locale
Hotline
  • The Therapy
    • Background
    • Fields of application for the CytoSorb Therapy
    • Ticagrelor and Rivaroxaban
    • Therapeutic aspects
    • COVID-19
    • Global decision support
    • Product safety
    • Testimonials
  • CytoScore
  • The Studies
    • Multicenter Studies
    • Monocenter studies
    • The CytoSorb-Registry
    • Case of the Month Submission
  • The Adsorber
    • Setup of CytoSorb
    • Usage and Application
    • Technical data
    • Q&A
  • Events
    • Event review
  • Support
    • Mediacenter
    • Reimbursement & Coding of CytoSorb Therapy
    • More Information about CytoSorb® therapy
    • Newsletter Registration
    • Hotline
  • About us
    • Corporation Management
    • CytoSorbents worldwide
    • Scientific partners
    • 10 Years CytoSorb® Therapy
    • Careers
    • Get in Contact

CytoSorb World Users’ Meeting | BEST BITS |

| Babylon Berlin | 2022

CytoSorb World Users’ Meeting

Babylon Berlin | 2022

ISICEM 2022 CytoSorbents Symposium: Hemoadsorption with CytoSorb

8. deutschsprachiges CytoSorb Anwendertreffen

Herausforderung septischer Schock – Worauf es ankommt

8th International CytoSorb Users Meeting

Hemoadsorption with CytoSorb in sepsis and COVID-19 patients – an update

Was kann die CytoSorb-Therapie bei der Behandlung des septischen Schocks leisten?

Reunión internacional de expertos | Cuidados Intensivos | Versión completa | Webinar 1

Overview about current data and latest findings

  • 1
  • 2
  • 3
  • Next
CytoSorbents Europe GmbH
Facebook-f Twitter Linkedin Youtube

CytoSorbents Europe GmbH
Müggelseedamm 131
12587 Berlin

support(at)cytosorbents.com

©2023 CYTOSORBENTS EUROPE GMBH | ALL RIGHTS RESERVED

*CytoSorb Therapy is the use of the CytoSorb adsorber in conditions where elevated levels of Cytokines and/or Bilirubin and/or Myoglobin exist. CytoSorb can also be used intraoperatively for the removal of Ticagrelor and/or Rivaroxaban during Cardiopulmonary-Bypass.

  • Privacy Information
  • Data protection
  • Disclaimer
  • Imprint
CytoSorbents Europe GmbH
  • The Therapy
    • Background
    • Fields of application for the CytoSorb Therapy
    • Ticagrelor and Rivaroxaban
    • Therapeutic aspects
    • COVID-19
    • Global decision support
    • Product safety
    • Testimonials
  • CytoScore
  • The Studies
    • Multicenter Studies
    • Monocenter studies
    • The CytoSorb-Registry
    • Case of the Month Submission
  • The Adsorber
    • Setup of CytoSorb
    • Usage and Application
    • Technical data
    • Q&A
  • Events
    • Event review
  • Support
    • Mediacenter
    • Reimbursement & Coding of CytoSorb Therapy
    • More Information about CytoSorb® therapy
    • Newsletter Registration
    • Hotline
  • About us
    • Corporation Management
    • CytoSorbents worldwide
    • Scientific partners
    • 10 Years CytoSorb® Therapy
    • Careers
    • Get in Contact
APPLY TODAY
JOBS
International (English)
  • Privacy Policy
  • Data protection
  • Disclaimer
  • Imprint